FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37617911000001105: Lorlatinib 25mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
399421000001111 Lorlatinib 25mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
399441000001118 Lorlatinib 25mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lorlatinib 25mg tablets Is a Lorlatinib false Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets Has specific active ingredient Lorlatinib false Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets Is a Lorlatinib true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets Has specific active ingredient Lorlatinib true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lorviqua 25mg tablets (Pfizer Ltd) Is a True Lorlatinib 25mg tablets Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets 120 tablet Has VMP True Lorlatinib 25mg tablets Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets 90 tablet Has VMP True Lorlatinib 25mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start